Hester Biosciences
HESTERBIO · Pharma > Pharmaceuticals & Drugs · Chairman: Bhupendra V Gandhi · MD: Rajiv Gandhi · Listing date: March 13, 2015 · Employees: 428 · Ahmedabad · http://www.hester.in

Stock Price vs Company Growth
1d
2.4%
1w
3.7%
1m
3.6%
3m
3.9%
6m
34.3%
1y
55.4%
5y
8.7%
all
19.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,378 2.4%
2,201
2,780
Company Overview

Sales
312 Cr
Growth: 4.0%
Profit after Tax
23.5 Cr
Growth: 21.2%
Small Cap
2,023 Cr
P/E: 76.9x
Industry P/E: 36.0x
Fundamentals

Sales (Cr) ₹ 312
Growth 4.0%
EBITDA 20.1%
P/S 6.5x
Dividend 0.5%
P/E 76.9x
Book Value ₹ 360
PEG Ratio 19.6x
ROE 7.9%
P/B 6.8x
Shareholding Pattern

Institutions
Kuntal Hasmukhlal Shah
3.05 %
Manish Jain
2.56 %
Darshna Dinesh Kapadia
1.81 %
Vinay Shah
1.28 %
Iepf
0.89 %
Promoters
Rajiv D Gandhi
10.47 %
Sanjiv Dinesh Gandhi
8.2 %
Nina R Gandhi
8.19 %
Ravin Gandhi
4.74 %
Bela Gandhi
4.71 %
Others
Increase    Decrease    No change
Company Profile Detailed

Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.
Investors (50)
Followers (10)